⚡ Quick Answer — What is Duova Inhaler?
Duova Inhaler is a dual bronchodilator combination inhaler for COPD, containing tiotropium (a long-acting muscarinic antagonist, LAMA) and formoterol (a long-acting β2 agonist, LABA). The two molecules attack airflow obstruction through complementary pathways — anticholinergic + β2 — giving deeper bronchodilation than either alone. Used as twice-daily maintenance for moderate-to-severe COPD. Each inhaler delivers tiotropium 9 mcg + formoterol 6 mcg per actuation, manufactured by Cipla at WHO-GMP certified facilities. International equivalent: No exact equivalent (Spiolto Respimat is closest in concept).
📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.
Why order from MedsBase
Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.
What Is Duova Inhaler?
Duova Inhaler combines a LAMA (tiotropium) and a LABA (formoterol) in a single inhaler. Dual bronchodilator therapy is the cornerstone of moderate-to-severe COPD management — landmark trials (FLAME, IMPACT, ETHOS) consistently show LAMA-LABA combinations reduce exacerbations and improve lung function more than LAMA alone or ICS-LABA alone in patients without elevated eosinophils.
How Does Duova Inhaler Work?
- Tiotropium blocks M3 muscarinic receptors on bronchial smooth muscle, relaxing parasympathetic tone for 24 hours.
- Formoterol activates β2-adrenergic receptors, raising cyclic AMP and producing rapid bronchodilation lasting 12 hours, with onset in 1–3 minutes.
- Synergy: the two pathways act in parallel — together they deliver greater bronchodilation than either alone, and reduce exacerbations more than monotherapy.
Uses and Indications
- Moderate-to-severe COPD maintenance — first-line dual bronchodilation at GOLD groups B and E
- COPD exacerbation prevention
- Frequent rescue-inhaler use on LAMA or LABA monotherapy
- Step-up from ICS-LABA in COPD without elevated eosinophils
Duova Inhaler Dosage
| Patient | Dose | Frequency |
|---|---|---|
| Adults — COPD maintenance | 2 inhalations | Twice daily |
How to Use Duova Inhaler Properly
- Shake the inhaler well; remove the cap.
- Breathe out fully away from the device.
- Seal lips around the mouthpiece.
- Press the canister at the start of a slow deep breath (3–5 seconds).
- Hold breath 10 seconds, then breathe out gently.
- Wait 30 seconds before second puff if needed.
- For ICS-containing combinations: rinse mouth, gargle, and spit out.
- Use a spacer for children, the elderly, and during acute illness.
Side Effects of Duova Inhaler
Common:
- Dry mouth (anticholinergic — usually mild)
- Mild tremor or palpitations (LABA effect)
- Throat irritation, mild cough on inhalation
- Headache, mild sinusitis
Less common:
- Constipation
- Urinary hesitancy (men with prostatic enlargement)
- Acute angle-closure glaucoma (rare; care with mist near eyes)
- Hypokalaemia at high doses (with diuretics, theophylline, oral steroids)
- Atrial fibrillation in susceptible patients
Serious — stop and seek help:
- Severe allergic reaction / anaphylaxis
- Paradoxical bronchospasm
- Acute eye pain, red eye, halos (suspected glaucoma — emergency)
- Acute urinary retention
Warnings and Precautions
- {$brand} is a controller, not a reliever. Keep a SABA (Asthalin, Levolin) for acute attacks.
- Use twice daily, every day.
- Avoid mist near eyes — risk of acute glaucoma in predisposed patients.
- Cardiovascular disease: use cautiously in arrhythmias, severe coronary disease.
- Prostatic obstruction: caution; risk of urinary retention.
- Hypersensitivity to milk protein — DPI formulations contain lactose.
Contraindications
- Known hypersensitivity to tiotropium, formoterol, atropine derivatives, or excipients
- Severe lactose / milk-protein hypersensitivity (DPI)
- Acute glaucoma — relative
- Severe symptomatic prostatic obstruction — relative
Drug Interactions
| Interacting drug | Effect | What to do |
|---|---|---|
| Other anticholinergics (oral, ophthalmic) | Additive dry mouth, urinary retention, glaucoma risk | Use with caution; monitor symptoms |
| Non-selective beta-blockers (propranolol, timolol) | Block formoterol — risk of severe bronchospasm | Avoid; switch to cardioselective if essential |
| Loop or thiazide diuretics | Additive hypokalaemia from formoterol | Monitor potassium with high doses |
| Theophylline / aminophylline | Additive hypokalaemia, tachycardia | Monitor heart rate and potassium |
| MAOIs and tricyclic antidepressants | Potentiate β-agonist cardiovascular effects | Caution — monitor BP/HR |
Storage
- Store below 25°C, protected from direct sunlight and heat.
- Do not refrigerate. Do not freeze.
- Do not puncture the canister; even an empty canister can explode if heated.
- Keep out of reach of children. Use within the expiry date printed on the canister.
Related Alternatives on MedsBase
- Foracort Inhaler — budesonide + formoterol ICS-LABA
- Seretide Accuhaler — fluticasone + salmeterol ICS-LABA
- Budecort Inhaler — budesonide ICS preventer
- Duova Inhaler — tiotropium + formoterol LAMA-LABA combo
- Triohale Inhaler — tiotropium + formoterol + ciclesonide triple
Frequently Asked Questions
How is Duova different from Tiova alone?
Duova adds formoterol (LABA) to tiotropium (LAMA). Dual bronchodilation gives greater lung function improvement and more exacerbation reduction in moderate-to-severe COPD compared to LAMA alone.
Is Duova for asthma or COPD?
Primarily COPD — landmark trials of LAMA-LABA dual therapy (FLAME, IMPACT, ETHOS) are in COPD. Asthma usually requires ICS-LABA first; severe asthma may add LAMA on top, but a triple therapy inhaler (Triohale) is more common than Duova in asthma.
When does Duova add benefit over LAMA alone?
For COPD with persistent dyspnoea, exercise limitation, or frequent exacerbations on LAMA monotherapy — adding LABA delivers measurable lung function and symptom gains.
How fast does Duova start working?
Formoterol component begins bronchodilation in 1–3 minutes. Tiotropium effect peaks at 1–3 hours; combined effect is sustained over 12 hours.
Can Duova replace ICS-LABA in COPD?
For COPD without elevated blood eosinophils and without frequent exacerbations, LAMA-LABA (Duova) is preferred over ICS-LABA. With frequent exacerbations or eosinophilic phenotype, triple therapy (LAMA-LABA-ICS, e.g. Triohale) is preferred.
Why dry mouth on Duova?
Anticholinergic effect from tiotropium. Usually mild; manage with sips of water, gum, oral hygiene.
Is Duova safe in pregnancy?
Limited data; not first-line. Discuss with your prescriber.
What if mist contacts my eyes?
Risk of acute glaucoma in predisposed patients. Aim away from eyes.
Should I keep my SABA reliever with Duova?
Yes — Duova is a controller, not a rescue inhaler. Keep Asthalin or Levolin for acute breathlessness.





























Reviews
There are no reviews yet